Cognitive Function and Fatigue After Brain Abscess
University of Oslo · NCT04938362
This study is testing how brain abscesses affect thinking skills and tiredness in people who have had this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | University of Oslo (other) |
| Locations | 1 site (Oslo) |
| Trial ID | NCT04938362 on ClinicalTrials.gov |
What this trial studies
Processing failed - manual review needed
Who should consider this trial
Good fit: Unknown
Not a fit: Unknown
Why it matters
Potential benefit: Unknown
How similar studies have performed: Unknown
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: • Patients who have completed treatment for brain abscess and who agree to participate. Exclusion criteria: * Patients who cannot undergo neuropsychological investigation due to unconsciousness * Patients who cannot undergo neuropsychological investigation, being mentally too ill * Patients who suffer from dementia * Patients who cannot undergo FDG-PET due to claustrophobia * Patients who cannot undergo EEG due to panic attacks * Age under 16.
Where this trial is running
Oslo
- Oslo University Hospital — Oslo, Norway (RECRUITING)
Study contacts
- Principal investigator: Bjørnar Hassel, MD, PhD — University of Oslo
- Study coordinator: Peder H Utne
- Email: pedutn@ous-hf.no
- Phone: +4723066023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Brain Abscess, Fatigue, Cognitive Dysfunction
Last reviewed 2026-05-15 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.